One of the most common questions people have is: “Do I qualify?” The answer depends on your health profile, not a simple number on a scale. Here’s how independent licensed providers generally evaluate candidacy and what you may want to know before a first consultation.
Clinical Eligibility Criteria
FDA guidelines and clinical evidence establish clear criteria for GLP-1 and related weight loss medications. An independent licensed provider typically uses these as a starting framework, then evaluates a person’s complete medical picture.
BMI-Based Criteria
The primary eligibility thresholds are:
- BMI 30 or higher: You may qualify for GLP-1 medication based on BMI alone. A BMI of 30 is the clinical threshold for obesity.
- BMI 27-29.9 with a weight-related condition: If your BMI falls in the overweight range AND you have a comorbidity like type 2 diabetes, hypertension, high cholesterol (dyslipidemia), obstructive sleep apnea, or cardiovascular disease, you may qualify.
Not sure what your BMI is? It’s calculated as weight in kilograms divided by height in meters squared. For reference, a 5’8″ person weighing 200 pounds has a BMI of approximately 30.4.
Beyond BMI: The Full Picture
BMI is a useful screening tool, but it doesn’t tell the whole story. An independent licensed provider also considers:
- Weight loss history: Have you tried diet and exercise, commercial programs, or other interventions without lasting success? A history of attempted weight loss strengthens the case for medical intervention.
- Current medications: Some medications cause weight gain as a side effect (certain antidepressants, beta-blockers, insulin, corticosteroids). A licensed provider evaluates how current medications interact with potential weight loss treatment.
- Metabolic health markers: Blood sugar levels, A1C, cholesterol panel, and blood pressure readings help an independent licensed provider understand a person’s metabolic baseline and choose the right medication class.
- Mental health considerations: Weight loss medication works best when combined with healthy coping strategies. A licensed provider screens for eating disorders and other conditions that require specialized support.
- Contraindications: Certain conditions may prevent you from using GLP-1 medications, including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, or severe gastrointestinal conditions.
Who Typically Qualifies
Based on clinical evidence and published guidelines, these profiles commonly qualify for GLP-1 or dual/triple agonist therapy when evaluated by an independent licensed provider:
Adults with Obesity (BMI 30+)
If your BMI is 30 or above and you’re an otherwise healthy adult, you’re likely a strong candidate. A licensed provider will confirm there are no contraindications and select the appropriate medication and starting dose.
Overweight Adults with Type 2 Diabetes
GLP-1 medications were originally developed for diabetes management. If you have type 2 diabetes and a BMI of 27+, these medications offer dual benefits — weight loss and improved blood sugar control. In clinical practice, some people reduce or eliminate diabetes medications as they lose weight, under their own provider’s supervision.
Adults with Hypertension or Cardiovascular Risk
Clinical trials show GLP-1 medications reduce cardiovascular risk factors beyond just weight loss. If you carry excess weight and have high blood pressure, elevated cholesterol, or other heart disease risk factors, medical weight loss may be both appropriate and protective.
People Who’ve Plateaued with Diet and Exercise
If you’ve genuinely committed to lifestyle changes and hit a wall, that’s not a personal failure. For many people, hormonal and metabolic factors create a biological ceiling that willpower alone can’t break through. GLP-1 medications address the biological barriers that keep the body from releasing stored fat.
Adults Managing Sleep Apnea or Joint Pain from Excess Weight
Obstructive sleep apnea and weight-bearing joint pain improve dramatically with weight loss. If excess weight is causing or worsening these conditions, a licensed provider may recommend GLP-1 therapy as part of a comprehensive treatment approach.
Who May Not Qualify (or Needs Additional Evaluation)
GLP-1 medications aren’t appropriate for everyone. A licensed provider will discuss alternatives if:
- You’re pregnant, planning pregnancy, or breastfeeding: GLP-1 medications are not approved for use during pregnancy. You must stop treatment at least 2 months before planning to conceive.
- You have a history of medullary thyroid carcinoma: Animal studies showed thyroid tumor risk. While human evidence is limited, this is a firm contraindication.
- You have pancreatitis: GLP-1 medications may increase pancreatitis risk. Active or recent pancreatitis typically disqualifies candidates.
- You have severe gastrointestinal disease: Conditions like gastroparesis or inflammatory bowel disease may be worsened by GLP-1 medications, which slow gastric emptying.
- Your BMI is under 27: Current FDA approval and clinical guidelines set BMI 27 (with comorbidities) as the minimum threshold. Vanity weight loss is outside the clinical scope of these medications.
What About People with Diabetes Already on Insulin?
Yes, many people on insulin can qualify for GLP-1 therapy — but medication management becomes more nuanced. When GLP-1 medications improve blood sugar control, insulin doses often need to be reduced to prevent hypoglycemia (dangerously low blood sugar). An independent licensed provider coordinates these adjustments carefully, monitoring a person’s blood sugar response over time.
This is one of the reasons independent provider oversight matters. Adjusting multiple diabetes and weight loss medications simultaneously requires clinical judgment, not algorithms.
How a Candidacy Evaluation Typically Works
With an independent licensed provider, a candidacy assessment usually follows a structured process:
- Health Assessment: You complete a detailed questionnaire covering medical history, current medications, weight history, allergies, and health goals. This typically takes 10-15 minutes.
- Provider Review: An independent licensed provider reviews the complete health profile. If additional information is needed (recent lab work, medical records from another provider), the provider's office may reach out.
- Telehealth Consultation: You meet the provider via secure video. They discuss your health picture, explain medication options, and answer questions. This consultation is meant to help you make an informed decision.
- Treatment Decision: If you and the provider agree that GLP-1 or related medication is appropriate, the provider determines the starting medication, dose, and follow-up schedule directly with you.
The time from initial assessment to starting treatment varies by provider and by whether additional health information is needed.
What If I’m Not Sure?
That’s exactly what an initial consultation is for. You don’t need to commit to anything before speaking with a provider. Many people come to a consultation unsure whether they qualify or whether medication is the right choice. A provider’s job is to give you clear information so you can decide.
GLP3 Weight Loss is an independent educational resource. We do not evaluate candidacy, prescribe, or provide care — we can help you connect with an independent licensed provider who does.
Find a Licensed Provider | Compare Medications
Disclaimer: Eligibility for GLP-1 or related medications is determined by an independent licensed provider based on individual medical evaluation. Meeting BMI criteria does not guarantee a prescription. This content is educational and does not constitute medical advice.